KALA BIO, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $121.6M | $221.6M | $77.3M |
| FY2021 | $122.6M | $139.4M | $92.1M |
| FY2022 | $67.8M | $86.8M | $70.5M |
| FY2023 | $48.4M | $55.9M | $50.9M |
| FY2024 | $43.2M | $55.5M | $51.2M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $121.6M | $221.6M | $77.3M |
| FY2021 | $122.6M | $139.4M | $92.1M |
| FY2022 | $67.8M | $86.8M | $70.5M |
| FY2023 | $48.4M | $55.9M | $50.9M |
| FY2024 | $43.2M | $55.5M | $51.2M |